Bedside Testing of CYP2C19 Gene for Treatment of Patients With PCI With Antiplatelet Therapy

NCT01823185 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

1500

Enrollment

OTHER

Sponsor class

Conditions

Coronary Artery Disease
Myocardial Infarction
Heart Disease
Vascular Disease
Angina Pectoris
Cardiovascular Disease
Ischemia
Infarction
Embolism
Thrombosis
Chest Pain

Interventions

DRUG: clopidogrel
DRUG: Ticagrelor or prasugrel

Sponsor

Imam Abdulrahman Bin Faisal University

Collaborators

[object Object]
[object Object]